The Future of Vaccine Development and Manufacturing – the benefits of combining IDT Biologika’s MVA technology platform with innovative analytical methods

Our scientists and technologists have the know-how and experience to characterize, develop and adapt the optimal process for each individual client project. Join the webinar and discover our MVA technology platform and explore the advantages for development and manufacturing of multiple vaccines and cell and gene therapeutics.

In this webinar, you will learn:

  • What are the specific challenges, opportunities of platform development processes?
  • What are the benefits for manufacturing rMVA-X vaccines?
  • What are the advantages of Rapid MVA quantification?
  • And more


Request Free!